Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 20:6:58.
doi: 10.1186/1758-5996-6-58. eCollection 2014.

Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society

Marcello Casaccia Bertoluci  1 , Augusto Pimazoni-Netto  2 , Antonio Carlos Pires  3 , Antonio Eduardo Pesaro  4 , Beatriz D Schaan  1 , Bruno Caramelli  5 , Carisi Anne Polanczyk  1 , Carlos Vicente Serrano Júnior  6 , Danielle M Gualandro  5 , Domingos Augusto Malerbi  7 , Emilio Moriguchi  1 , Flavio Antonio de Oliveira Borelli  8 , João Eduardo Nunes Salles  9 , José Mariani Júnior  9 , Luis Eduardo Rohde  1 , Luis H Canani  1 , Luiz Antonio Machado Cesar  5 , Marcos Tambascia  10 , Maria Tereza Zanella  2 , Miguel Gus  11 , Rafael Selbach Scheffel  11 , Raul Dias Dos Santos  5
Affiliations
Review

Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society

Marcello Casaccia Bertoluci et al. Diabetol Metab Syndr. .

Abstract

There is a very well known correlation between diabetes and cardiovascular disease but many health care professionals are just concerned with glycemic control, ignoring the paramount importance of controlling other risk factors involved in the pathogenesis of serious cardiovascular diseases. This Position Statement from the Brazilian Diabetes Society was developed to promote increased awareness in relation to six crucial topics dealing with diabetes and cardiovascular disease: Glicemic Control, Cardiovascular Risk Stratification and Screening Coronary Artery Disease, Treatment of Dyslipidemia, Hypertension, Antiplatelet Therapy and Myocardial Revascularization. The issue of what would be the best algorithm for the use of statins in diabetic patients received a special attention and a new Brazilian algorithm was developed by our editorial committee. This document contains 38 recommendations which were classified by their levels of evidence (A, B, C and D). The Editorial Committee included 22 specialists with recognized expertise in diabetes and cardiology.

Keywords: Antiplatelet therapy; Cardiovascular risk stratification; Diabetes; Glicemic control; Hypertension; Myocardial revascularization; Screening coronary artery disease; Treatment of dyslipidemia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example of calculating cardiovascular risk with the use of a UKPDS calculator, considering the parameters provided.
Figure 2
Figure 2
Decision making flow for statin use.
See this image and copyright information in PMC

References

    1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352(9131):837–853. - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1998;352(9131):854–865. - PubMed
    1. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559. - PMC - PubMed
    1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. doi: 10.1056/NEJMoa0806470. - DOI - PubMed

LinkOut - more resources